title: Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.
abstract: Although polymorphonuclear leukocytes (PMNs) are powerfully anti-Aspergillus, transfusion therapy remains controversial, with conflicting results, and experimental support has been lacking. We devised a pulmonary infection model in neutropenic BALB/c mice, used an antibacterial regimen to prevent confounding sepsis, and optimized PMN induction, purifications, and dose. Mice were given 150 mg/kg cyclophosphamide every 4 days and a gentamicin-vancomycin-clindamycin-imipenem regimen daily beginning 4 days before intranasal challenge with 5 × 10(5) Aspergillus conidia. This regimen produced leukopenia (~10% of normal white blood cell [WBC] count; ≤ 10% PMNs) for 10 days, without bacterial superinfection. PMN donors given 100 μg/kg recombinant murine granulocyte colony-stimulating factor (G-CSF) for 10 days yielded 11 × 10(7) to 13.6 × 10(7) WBC/ml (81 to 87% PMNs). Infected mice were given PMN transfusions intravenously. In 2 experiments with up to 70% mortality of neutropenic controls, transfusion of 10(7) PMNs 1 and 4 days after challenge had negligible effects on peripheral WBC counts but improved survival (P = 0.007, 0.02), decreased lung CFU (P = 0.03, 0.005), and cleared infection in 28 to 50% of survivors. Transfusion of 5 × 10(6) PMNs showed partial protection. Transfusions given every other day did not improve protection. Our present results provide an experimental basis for enthusiasm for PMN transfusions in the therapy of aspergillosis in humans.
authors: California Institute for Medical Research, San Jose, California, USA.
authors: Marife
authors: M
authors: Martinez
authors: Vicky
authors: V
authors: Chen
authors: Ann-Jay
authors: AJ
authors: Tong
authors: Kelsey
authors: K
authors: Hamilton
authors: Karl V
authors: KV
authors: Clemons
authors: David A
authors: DA
authors: Stevens
mesh_terms: D000818:Animals; D001232:Aspergillus fumigatus / Q000472:pathogenicity; D006098:Granulocytes / Q000637:transplantation*; D007165:Immunosuppression Therapy; D017708:Leukocyte Transfusion / Q000379:methods*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009503:Neutropenia / Q000628:therapy; D009504:Neutrophils / Q000166:cytology / Q000502:physiology; D055732:Pulmonary Aspergillosis / Q000628:therapy*
references: Blood. 2000 Jun 1;95(11):3302-9
references: 10828009
references: Haematologica. 2004 May;89(5):632-3
references: 15136239
references: Curr Control Trials Cardiovasc Med. 2002 Jan 8;3(1):4
references: 11985778
references: Aust N Z J Med. 1996 Dec;26(6):813-8
references: 9028513
references: Ann Hematol. 2005 Oct;84(11):734-41
references: 15951986
references: Pediatrics. 1973 Feb;51(2):230-3
references: 4572067
references: Cytokines Cell Mol Ther. 2000 Jun;6(2):89-95
references: 11108574
references: J Clin Apher. 2006 Apr;21(1):65-71
references: 16619227
references: J Med Vet Mycol. 1992;30(6):485-8
references: 1287169
references: Ther Apher Dial. 2005 Apr;9(2):137-41
references: 15828925
references: Med Mycol. 2005 May;43 Suppl 1:S101-10
references: 16110800
references: Bone Marrow Transplant. 2004 Nov;34(10):839-46
references: 15273712
references: Transfusion. 1981 Nov-Dec;21(6):739-43
references: 7314224
references: Transfusion. 1994 Jul;34(7):630-46
references: 8053044
references: Control Clin Trials. 1999 Oct;20(5):408-22
references: 10503801
references: Cancer. 2004 Dec 15;101(12):2859-65
references: 15529309
references: Transfusion. 2005 Dec;45(12):1876-89
references: 16371040
references: J Pediatr Hematol Oncol. 2009 Mar;31(3):166-72
references: 19262241
references: Transfus Med. 2007 Aug;17(4):296-303
references: 17680956
references: Med Mycol. 2011 Nov;49(8):834-47
references: 21539507
references: J Med Vet Mycol. 1995 Sep-Oct;33(5):311-7
references: 8544084
references: Transfusion. 2006 Jan;46(1):1-5
references: 16398722
references: Med Mycol. 2006 Sep 1;44(Supplement_1):S383-S386
references: 30408933
references: Transfusion. 1994 Mar;34(3):226-32
references: 8146895
references: Antimicrob Agents Chemother. 1991 Jul;35(7):1329-33
references: 1929289
references: J Pediatr Hematol Oncol. 2009 Mar;31(3):161-5
references: 19262240
references: N Engl J Med. 1974 May 9;290(19):1055-62
references: 4207026
references: Semin Hematol. 2007 Jan;44(1):15-23
references: 17198843
references: Curr Opin Hematol. 2006 Jan;13(1):45-9
references: 16319687
references: Med Mycol. 2006 Sep 1;44(Supplement_1):S119-S126
references: 30408894
references: Transfusion. 1998 Aug;38(8):710-2
references: 9709777
references: Haematologica. 2009 Dec;94(12):1661-8
references: 19996117
references: Haematologica. 2008 Jul;93(7):1058-67
references: 18508794
references: Med Mycol. 2006 Feb;44(1):69-73
references: 16805095
references: Transfusion. 2002 Nov;42(11):1414-21
references: 12421213
references: Am J Med. 1984 Jan;76(1):162-6
references: 6419603
references: Curr Opin Hematol. 2009 Jan;16(1):1-2
references: 19057197
references: Br J Haematol. 2004 Dec;127(5):501-8
references: 15566353
references: Leukemia. 1997 Oct;11(10):1621-30
references: 9324280
references: Cytotherapy. 2003;5(1):19-30
references: 12745586
references: Br J Haematol. 1999 Sep;106(3):689-96
references: 10468857
references: Bone Marrow Transplant. 1997 Apr;19(8):809-12
references: 9134173